Literature DB >> 29353683

Diagnosing upper extremity deep vein thrombosis with non-contrast-enhanced Magnetic Resonance Direct Thrombus Imaging: A pilot study.

C E A Dronkers1, F A Klok2, G R van Haren3, J Gleditsch4, E Westerlund5, M V Huisman2, L J M Kroft3.   

Abstract

Diagnosing upper extremity deep vein thrombosis (UEDVT) can be challenging. Compression ultrasonography is often inconclusive because of overlying anatomic structures that hamper compressing veins. Contrast venography is invasive and has a risk of contrast allergy. Magnetic Resonance Direct Thrombus Imaging (MRDTI) and Three Dimensional Turbo Spin-echo Spectral Attenuated Inversion Recovery (3D TSE-SPAIR) are both non-contrast-enhanced Magnetic Resonance Imaging (MRI) sequences that can visualize a thrombus directly by the visualization of methemoglobin, which is formed in a fresh blood clot. MRDTI has been proven to be accurate in diagnosing deep venous thrombosis (DVT) of the leg. The primary aim of this pilot study was to test the feasibility of diagnosing UEDVT with these MRI techniques. MRDTI and 3D TSE-SPAIR were performed in 3 pilot patients who were already diagnosed with UEDVT by ultrasonography or contrast venography. In all patients, UEDVT diagnosis could be confirmed by MRDTI and 3D TSE-SPAIR in all vein segments. In conclusion, this study showed that non-contrast MRDTI and 3D TSE-SPAIR sequences may be feasible tests to diagnose UEDVT. However diagnostic accuracy and management studies have to be performed before these techniques can be routinely used in clinical practice.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Diagnosis; Magnetic resonance imaging; Upper extremity deep vein thrombosis; Venous thrombo-embolism

Mesh:

Year:  2018        PMID: 29353683     DOI: 10.1016/j.thromres.2018.01.015

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  4 in total

1.  Usefulness of non-contrast-enhanced magnetic resonance imaging prior to venous interventions.

Authors:  Agnieszka Kusiak; Jacek Budzyński
Journal:  Postepy Kardiol Interwencyjnej       Date:  2019-09-18       Impact factor: 1.426

Review 2.  SCMR Position Paper (2020) on clinical indications for cardiovascular magnetic resonance.

Authors:  Tim Leiner; Jan Bogaert; Matthias G Friedrich; Raad Mohiaddin; Vivek Muthurangu; Saul Myerson; Andrew J Powell; Subha V Raman; Dudley J Pennell
Journal:  J Cardiovasc Magn Reson       Date:  2020-11-09       Impact factor: 5.364

Review 3.  Theranostic nanoparticles for the management of thrombosis.

Authors:  Peije Russell; Christoph Eugen Hagemeyer; Lars Esser; Nicolas Hans Voelcker
Journal:  Theranostics       Date:  2022-03-14       Impact factor: 11.600

4.  Quadrilateral space region inflammation and other incidental findings on shoulder MRI following recent COVID-19 vaccination: Three case reports.

Authors:  Matthew Eisenberg; Christopher Tingey; Oliver Fulton; Josh Owen; Travis Snyder
Journal:  Radiol Case Rep       Date:  2021-07-19
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.